The KRT1 Knockout HAP1 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal human cell population with targeted disruption of the KRT1 gene. This polyclonal knockout model is generated in the near-haploid HAP1 cell line and serves as a loss-of-function resource for investigating the biological roles of keratin 1. By eliminating KRT1 expression, the model allows researchers to dissect the contributions of this type II intermediate filament protein to cytoskeletal architecture, cell adhesion, and epithelial differentiation, without the need for single-cell clone isolation or characterization of specific editing outcomes.
HAP1 is a near-haploid line derived from the KBM-7 chronic myeloid leukemia cell background, widely utilized in functional genomics due to the simplified generation of homozygous-like gene disruptions via CRISPR/Cas9. Despite its leukemic origin, HAP1 cells exhibit epithelial-like characteristics, including residual intermediate filament networks and adhesion complex components, making them a tractable platform for studying structural proteins such as keratins. Their haploid genome facilitates high-efficiency knockout and reduces confounding effects from heterozygous alleles, enabling robust phenotypic analyses in a genetically uniform population.
Keratin 1 functions as a key structural component of intermediate filaments in suprabasal epidermal keratinocytes, where it heterodimerizes with keratin 10 (KRT10) to form resilient filament bundles that confer mechanical integrity to the skin. Upstream, KRT1 expression is regulated by calcium influx, AP-1 transcription factors, p63, and Notch signaling, integrating signals from the calcium-sensing receptor (CASR) and protein kinase C (PKC). In its normal context, the KRT1-KRT10 network associates with desmosomal proteins such as desmoplakin (DSP) and plakoglobin (JUP), anchoring filaments to cell?Ccell junctions. Upon KRT1 disruption, these interactions are compromised, leading to altered cytoskeletal organization, impaired cell adhesion, and compensatory upregulation of other keratins like KRT6. The pathway extends to terminal differentiation effectors including involucrin and transglutaminase 1, positioning KRT1 as a central hub in epithelial barrier maintenance and mechanotransduction.
In the HAP1 background, KRT1 ablation dismantles the residual intermediate filament scaffold, offering a simplified model to observe keratin network dynamics and downstream consequences. The polyclonal nature of the edited population captures a range of gene-disruption events, mimicking the heterogeneous cellular responses seen in disease states such as epidermolytic hyperkeratosis. Because HAP1 cells can be cultured and assayed in high-throughput formats, this model is particularly valuable for screening compounds that modulate keratin expression or for performing genetic modifier screens under conditions that stress the epithelial cytoskeleton.
Applications include high-content immunofluorescence imaging to visualize keratin network collapse, RT-qPCR and Western blotting to quantify KRT1 and compensatory gene expression, transcriptomic profiling via RNA-seq to map global changes upon KRT1 loss, and drug sensitivity assays to test the role of keratin 1 in resistance to mechanical or osmotic stress. The haploid background further enables functional genomics approaches such as insertional mutagenesis screens to identify synthetic lethal partners or novel regulators of intermediate filament biology. For further technical details, please contact Ascent Research.
